Tara Jones
( out of 276 reviews )

Tara Jones, FACC, FSCAI, MD, PharmD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

50 N Medical Dr
Salt Lake City , UT 84132
801-585-7676
Get Directions

Mountain West Medical Group Specialty Clinic at MWMC

Mountain West U Specialty Clinic
196 E 2000 N
Tooele , UT 84074
435-843-2725
Get Directions

Cardiovascular Center

Cardiovascular Center
50 N Medical Dr
Salt Lake City , UT 84132
801-585-7676
Get Directions

Tara Jones, MD, PharmD is an Associate Professor of Cardiovascular Medicine at the University of Utah School of Medicine and a member of the Interventional Cardiology faculty.

Dr. Jones graduated from the South Dakota State University College of Pharmacy where she received her Bachelor of Science in Pharmaceutical Sciences in 2005 and her Doctorate of Pharmacy in 2007. She then graduated from the University of South Dakota Sanford School of Medicine with her MD in 2012. She completed her Internal Medicine residency at the University of Nebraska Medical Center and her Cardiovascular Fellowship at the University of Washington. She subsequently came to the University of Utah to complete her Interventional Cardiology and Structural Heart Disease Fellowships.

Dr. Jones specializes in both interventional cardiology and structural heart disease cases including Transcatheter Aortic Valve Replacement (TAVR). Her clinical responsibilities include:

  • invasive management of acute heart attacks
  • evaluation and management of valvular heart disease
  • coronary stent implantation/balloon angioplasty
  • PFO/ASD closure

She is also an active researcher, with her academic interests focused on cardiogenic shock, acute coronary syndromes, and structural heart disease. She has authored several articles in cardiovascular journals focusing on these interests. In her free time, she enjoys skiing, hiking, and running.

She will be seeing patients as part of our Interventional and Structural Heart Disease program as well as general cardiology.

Specialties

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine (Sub: Cardiovascular Disease)
American Board of Internal Medicine (Sub: Interventional Cardiology)

Patient Rating

Patients describe Dr. Jones as attentive, compassionate, and personable, frequently noting that she takes time to listen and explains diagnoses and procedures clearly. Many comments highlight her strong bedside manner, clinical knowledge, and thorough follow-up, including coordinating care or recommending other specialists when appropriate. Reviewers express trust in her judgment and appreciation for practical, reassuring care that helps them make a plan for their health.

Generated via Patient Reviews

4.9 /5
( out of 276 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Tara Jones, MD, PharmD is an Associate Professor of Cardiovascular Medicine at the University of Utah School of Medicine and a member of the Interventional Cardiology faculty.

Dr. Jones graduated from the South Dakota State University College of Pharmacy where she received her Bachelor of Science in Pharmaceutical Sciences in 2005 and her Doctorate of Pharmacy in 2007. She then graduated from the University of South Dakota Sanford School of Medicine with her MD in 2012. She completed her Internal Medicine residency at the University of Nebraska Medical Center and her Cardiovascular Fellowship at the University of Washington. She subsequently came to the University of Utah to complete her Interventional Cardiology and Structural Heart Disease Fellowships.

Dr. Jones specializes in both interventional cardiology and structural heart disease cases including Transcatheter Aortic Valve Replacement (TAVR). Her clinical responsibilities include:

  • invasive management of acute heart attacks
  • evaluation and management of valvular heart disease
  • coronary stent implantation/balloon angioplasty
  • PFO/ASD closure

She is also an active researcher, with her academic interests focused on cardiogenic shock, acute coronary syndromes, and structural heart disease. She has authored several articles in cardiovascular journals focusing on these interests. In her free time, she enjoys skiing, hiking, and running.

She will be seeing patients as part of our Interventional and Structural Heart Disease program as well as general cardiology.

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor (Clinical)
Academic Divisions Cardiovascular Medicine
Board Certification
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Cardiovascular Disease)
American Board of Internal Medicine (Sub: Interventional Cardiology)

Education history

Fellowship Structural Heart Interventional Cardiology - University of Utah School of Medicine Fellow
Fellowship Interventional Cardiology - University of Utah School of Medicine Fellow
Fellowship Cardiology - University of Washington School of Medicine Fellow
Residency Internal Medicine - University of Nebraska Medical Center Resident
Professional Medical Medicine - University of South Dakota Sanford School of Medicine M.D.
Doctoral Training South Dakota State University Pharm.D.
Undergraduate Pharmaceutical Sciences - South Dakota State University B.S.

Selected Publications

Journal Article

  1. Kyriakopoulos CP, Taleb I, Sideris K, Maneta E, Hamouche R, Tseliou E, Krauspe E, Selko S, Carter S, Jones TL, Zhang C, Presson AP, Dranow E, Geer L, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos SG (2025). Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a Hub. J Am Heart Assoc, 14(4), e035464.
  2. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K, Tseliou E, Shah KS, Tonna JE, Dranow E, Jones TL, Carter SJ, Fang JC, Stehlik J, Ohsfeldt RL, Selzman CH, Hanff TC, Drakos SG (2024). Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circ Heart Fail, 17(11), e011709.
  3. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Hamouche R, Tseliou E, Zhang C, Presson AP, Dranow E, Shah KS, Jones TL, Fang JC, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos SG (2024). Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic Shock. Circ Heart Fail, 17(9), e011358.
  4. Gamvroulas EM, Jones AE, Saunders JA, Jones TL, Witt DM (2023). Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients. BMC Cardiovasc Disord, 23(1), 117.
  5. Jain P, Thayer KL, Abraham J, Everett KD, Pahuja M, Whitehead EH, Schwartz BP, Lala A, Sinha SS, Kanwar MK, Garan AR, Hernandez-Monfort JA, Mahr C, Vorovich E, Wencker D, McCabe JM, Jones T, Goud M, Baca P, Harwani N, Burkhoff D, Kapur NK (2021). Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock. J Card Fail, 27(10), 1061-1072.
  6. Jones TL, Golomb M, Dranow E, Welt FGP, Shah PB (2020). The case for a qualitative lesion assessment system for coronary angiography. Catheter Cardiovasc Interv, 98(3), 520-525.
  7. Sturm RC, Jones TL, Youngquist ST, Shah RU (2021). Regional systems of care in ST elevation myocardial infarction. Interv Cardiol Clin, 10(3), 281-291.
  8. Varela DL, Jones TL (2021). Perivalvular Abscess Causing Coronary-Artery Compression. N Engl J Med, 385(1), e3.
  9. Alasnag M, Jones TL, Hanfi Y, Ryan N (2021). Sex-based outcomes in contemporary antiplatelet therapy trials. Open Heart, 8(2).
  10. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos SG (2021). Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheter Cardiovasc Interv.
  11. Tandar A, Sharma V, Ibrahim M, Jones T, Morgan D, Montzingo C, Lee J, Birgenheier N, Silberton N, Abraham A, Welt FGP, Glotzbach JP (2021). Preventing or minimizing acute kidney injury in patients undergoing transcatheter aortic valve replacement. J Invasive Cardiol, 33(1), E32-39.
  12. Mayeux JD, Pan IZ, Dechand J, Jacobs JA, Jones TL, McKellar SH, Beck E, Hatton ND, Ryan JJ (2020). Management of Pulmonary Arterial Hypertension. Curr Cardiovasc Risk Rep.
  13. Jones TL, Golomb M, Dranow E, Welt FGP, Shah PB (2020). The case for a qualitative lesion assessment system for coronary angiography. Catheter Cardiovasc Interv, 98(3), 520-525.
  14. Jones TL, Gowani SA, Abraham A, Sharma V, Glotzbach J, Morgan D, Welt FGP, Tandar A (2020). Trans-septal puncture through Gore® Cardioform Septal Occluder device - Step by step approach. Cardiovasc Revasc Med, 23, 91-93.
  15. Dawson K, Jones TL, Kearney KE, McCabe JM (2020). Emerging Role of Large-bore Percutaneous Axillary Vascular Access: A Step-by-step Guide. Interv Cardiol, 15, e07.
  16. Jones TL, Tan MC, Nguyen V, Kearney KE, Maynard CC, Anderson E, Mahr C, McCabe JM (2020). Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock. ESC Heart Fail, 7(3), 1118-1124.
  17. Mercanti F, Rosseel L, Neylon A, Bagur R, Sinning J, Nickenig G, Grube E, Hildick-Smith D, Tavano D, Wolf A, Colonna G, Latib A, Mitomo S, Petronio A, Angelillis M, Tchetche D, De Biase C, Adamo M, Nejjari M, Digne F, Schafer U, Amabile N, Achkouty G, Makkar R, Yoon S, Finkelstein A, Dvir D, Jones T, Chevalier B, Lefevre T, Piazza N, Mylotte D (2020). Chimney stenting for coronary occlusion during Transcatheter Aortic Valve Replacement: Insights from the Chimney Registry. JACC Cardiovasc Interv, 13(6), 751-761.
  18. Simonato M, Webb J, Bleiziffer S, Abdel-Wahab M, Wood D, Seiffert M, Schfer U, Whrle J, Jochheim D, Woitek F, Latib A, Barbanti M, Spargias K, Kodali S, Jones T, Tchetche D, Coutinho R, Napodano M, Garcia S, Veulemans V, Siqueira D, Windecker S, Cerillo A, Kempfert J, Agrifoglio M, Bonaros N, Schoels W, Baumbach H, Schofer J, Gaia DF, Dvir D (2019). Current Generation Balloon-Expandable Transcatheter Valve Positioning Strategies During Aortic Valve-in-Valve Procedures and Clinical Outcomes. JACC Cardiovasc Interv, 12(16), 1606-1617.
  19. Jones TL, Kearney KE, McCabe JM (2019). Prevalence and Predictors of Vascular Thrombus Formation After Percutaneous Axillary Artery Impella Insertion. Circ Cardiovasc Interv, 12(8), e008046.
  20. Jones TL, Nakamura K, McCabe JM (2019). Cardiogenic shock: evolving definitions and future directions in management. Open Heart, 6(1), e000960.
  21. Bleiziffer S, Erlebach M, Simonato M, Pibarot P, Webb J, Capek L, Windecker S, George I, Sinning JM, Horlick E, Napodano M, Holzhey DM, Petursson P, Cerillo A, Bonaros N, Ferrari E, Cohen MG, Baquero G, Jones TL, Kalra A, Reardon MJ, Chhatriwalla A, Gama Ribeiro V, Alnasser S, Van Mieghem NM, Rustenbach CJ, Schofer J, Garcia S, Zeus T, Champagnac D, Bekeredjian R, Kornowski R, Lange R, Dvir D (2018). Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve. Heart, 104(10), 828-834.
  22. Jones TL, McCabe JM (2017). Cardiovascular highlights from non-cardiology journals. Heart, 103, 1553.
  23. Haglund NA, Burdorf A, Jones T, Shostrom V, Um J, Ryan T, Shillcutt S, Fischer P, Cox ZL, Raichlin E, Anderson DR, Lowes BD, Dumitru I (2015). Inhaled Milrinone After Left Ventricular Assist Device Implantation. J Card Fail, 21(10), 792-7.

Review

  1. Turner ME, Jones T, Bauser-Heaton H (2024). Considerations for Women with Congenital Heart Disease Undergoing Percutaneous Cardiovascular Procedures. [Review]. Interv Cardiol Clin, 14(1), 97-107.
  2. Alasnag M, Ahmed B, Jones T, Ibebuogu U, Price A, Spencer D, Welt F, Batchelor W (2023). Cardiac Catheterization Laboratory Sustainability: What It Is and Why It Matters. [Review]. JACC Cardiovasc Interv.
  3. Tandar A, Sharma V, Ibrahim M, Jones T, Morgan D, Montzingo C, Lee J, Birgenheier N, Silverton N, Abraham A, Welt FGP, Glotzbach JP (2021). Preventing or Minimizing Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement. [Review]. J Invasive Cardiol, 33(1), E32-E39.

Book Review

  1. Goldberger Z, Jones T (2016). Book Review. [Review of the book ECG from Basics to Essentials: Step by Step]. 39, 779.

Case Report

  1. Jones TL, Sharma V, Glotzbach JP, Welt FGP, Tandar A (2020). Is timing everything? Bioprosthetic valve fracture in valve-in-valve TAVR. J Card Surg, 35(11), 3242-3243.

Editorial

  1. Fang JC, Jones TL (2020). Can a Pulmonary Artery Catheter Improve Outcomes in Cardiogenic Shock? JACC Heart Fail, 8(11), 914-916.

Abstract

  1. Jones T, Taleb I, Dranow E, Chaney J, McKellar S, Koliopoulou AG, Selzman C, Fang J, Nativi-Nicolau, Tonna J, Overton S, Stehlik J, Welt F, Tandar A, Drakos S (2020). SCAI cardiogenic shock classification system to predict survival. [Abstract]. 75(11 Supplement 1), 995.

News & Podcasts

News

Schedule Online